Oral Bacteria May Drive Alzheimer's Disease Through Brain Inflammation

This extensive review synthesizes emerging evidence linking oral microbiome dysbiosis to Alzheimer's disease pathogenesis, revealing a potentially modifiable risk factor for the world's most common form of dementia. The oral cavity harbors over 800 bacterial species, and when this ecosystem becomes imbalanced, certain pathogenic bacteria may contribute to neurodegeneration through multiple pathways.

The researchers identified three key periodontal pathogens—Porphyromonas gingivalis, Treponema denticola, and Fusobacterium nucleatum—that produce virulence factors capable of crossing the blood-brain barrier. P. gingivalis, in particular, releases gingipain proteases that directly promote amyloid beta aggregation and tau hyperphosphorylation, hallmarks of Alzheimer's pathology. When detected in brain tissue, P. gingivalis correlates with a 6-10 fold increased risk of developing AD.

The review reveals a bidirectional relationship where oral dysbiosis drives neuroinflammation through cytokine release (IL-1β, IL-6, TNF-α), while AD-related cognitive decline may worsen oral hygiene, creating a vicious cycle. Systemic conditions like diabetes, hypertension, and chronic kidney disease amplify this risk by promoting shared inflammatory pathways and microbial imbalances.

Promisingly, the research identifies potential therapeutic interventions including gingipain inhibitors (like COR388), antimicrobials, probiotics, and prebiotics. The review also highlights non-invasive biomarker potential, with salivary Veillonella and gingival crevicular fluid pathogens showing promise for early AD detection.

While the evidence is compelling, the authors acknowledge that causality remains to be definitively established, as most studies are observational or rely on animal models. Nevertheless, this work opens new avenues for AD prevention through oral health maintenance and targeted microbial interventions.